To determine the association of ACSL3 with sorafenib resistance in HCC, we established resistant cell lines, Huh7 (Huh7-DR3) and PLC/PRF/5 (PLC/PRF/5-DR3), by culturing them with increasing doses of sorafenib (Figure 3A). Here, ACSL3 is linked to hepatocellular carcinoma.